Biomerica (BMRA) Short term Debt (2011 - 2012)
Biomerica's (BMRA) quarterly Short term Debt came in at $43000.0 in Q2 2012, up 21.5% year-on-year from $35390.0 in Q2 2011, and up 266.21% quarter-over-quarter from $11742.0 in Q4 2011.
Biomerica (BMRA) Short term Debt (2011 - 2012) Analysis & Trends
Biomerica has disclosed Short term Debt across 2 years of filings, most recently posting $43000.0 for Q2 2012.
- Short term Debt for Q2 2012 came in at $43000.0, up 21.5% year-over-year; the trailing twelve-month figure through May 2012 was $43000.0 (up 21.5% YoY), and the FY2012 annual result was $43000.0, up 21.5% from the prior year.
- Short term Debt came in at $43000.0 for Q2 2012 at Biomerica, up from $11742.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $43000.0 in Q2 2012 to a low of $11742.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Biomerica | 5.57 Mn | 4.23 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 43,000.00 |
| Nov 30, 2011 | 11,742.00 |
| Aug 31, 2011 | 23,664.00 |
| May 31, 2011 | 35,390.00 |